"Glycosphingolipids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids (GANGLIOSIDES); SULFOGLYCOSPHINGOLIPIDS (formerly known as sulfatides), glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. (From IUPAC's webpage)
| Descriptor ID |
D006028
|
| MeSH Number(s) |
D09.400.410.420 D10.390.470 D10.570.877.360
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glycosphingolipids".
Below are MeSH descriptors whose meaning is more specific than "Glycosphingolipids".
This graph shows the total number of publications written about "Glycosphingolipids" by people in this website by year, and whether "Glycosphingolipids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glycosphingolipids" by people in Profiles.
-
Leishmania surface molecule lipophosphoglycan-TLR2 interaction moderates TPL2-mediated TLR2 signalling for parasite survival. Immunology. 2024 Jan; 171(1):117-130.
-
Histo-blood group antigens of glycosphingolipids predict susceptibility of human intestinal enteroids to norovirus infection. J Biol Chem. 2020 11 20; 295(47):15974-15987.
-
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer. Nat Commun. 2020 08 27; 11(1):4279.
-
Defective Association of the Platelet Glycoprotein Ib-IX Complex with the Glycosphingolipid-Enriched Membrane Domain Inhibits Murine Thrombus and Atheroma Formation. J Immunol. 2016 07 01; 197(1):288-95.
-
Bioactive lipids in emphysema. Decoding fat to reveal COPD phenotypes. Am J Respir Crit Care Med. 2015 Feb 01; 191(3):241-3.
-
My career as an immunoglycobiologist. Proc Jpn Acad Ser B Phys Biol Sci. 2013; 89(6):257-69.
-
C-Glycosphingolipids with an exo-methylene substituent: stereocontrolled synthesis and immunostimulation of mouse and human natural killer T lymphocytes. Chembiochem. 2012 Aug 13; 13(12):1733-7.
-
Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation. 2007 Apr; 75(4):279-91.
-
Cross-immunity and antibody responses to different immobilisation serotypes of Ichthyophthirius multifiliis. Fish Shellfish Immunol. 2007 Jun; 22(6):589-97.
-
Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 2005 Mar 24; 434(7032):520-5.